GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (WBO:NZYM) » Definitions » Change In Receivables

Novonesis AS (WBO:NZYM) Change In Receivables : €-24 Mil (TTM As of Dec. 2023)


View and export this data going back to 2018. Start your Free Trial

What is Novonesis AS Change In Receivables?

Novonesis AS's change in receivables for the quarter that ended in Dec. 2023 was €-11 Mil. It means Novonesis AS's Accounts Receivable increased by €11 Mil from Sep. 2023 to Dec. 2023 .

Novonesis AS's change in receivables for the fiscal year that ended in Dec. 2023 was €-24 Mil. It means Novonesis AS's Accounts Receivable increased by €24 Mil from Dec. 2022 to Dec. 2023 .

Novonesis AS's Accounts Receivable for the quarter that ended in Dec. 2023 was €497 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Novonesis AS's Days Sales Outstanding for the three months ended in Dec. 2023 was 73.39.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Novonesis AS's liquidation value for the three months ended in Dec. 2023 was €-1,113 Mil.


Novonesis AS Change In Receivables Historical Data

The historical data trend for Novonesis AS's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS Change In Receivables Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Change In Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only -31.86 53.09 -77.19 -44.36 -23.75

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Change In Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -21.24 -35.20 22.57 -0.13 -11.00

Novonesis AS Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-24 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS  (WBO:NZYM) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Novonesis AS's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

Days Sales Outstanding
=Accounts Receivable/Revenue*Days in Period
=496.684/617.568*91
=73.39

2. In Ben Graham's calculation of liquidation value, Novonesis AS's accounts receivable are only considered to be worth 75% of book value:

Novonesis AS's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

Liquidation Value
=Cash, Cash Equivalents, Marketable Securities-Total Liabilities+(0.75 * Accounts Receivable)+(0.5 * Total Inventories)
=155.096-1883.695+0.75 * 496.684+0.5 * 486.621
=-1,113

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Novonesis AS Change In Receivables Related Terms

Thank you for viewing the detailed overview of Novonesis AS's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (WBO:NZYM) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (WBO:NZYM) Headlines

No Headlines